Sr Dir, Global Business Intelligence & Commercial Operations

Apellis Pharmaceuticals•Waltham, MA

23h•$219,000 - $329,000•Onsite

About The Position

We are looking for a Head of Business Intelligence & Analytics who will play a key role in the commercialization of Empaveli. They will be accountable for leading the insights and analytics function and partnering closely U.S. leadership to influence strategies based on integrated and actionable insights from key customer/stakeholder groups. The ideal candidate should have experience leading an insights and analytics function within a commercial biotech or pharmaceutical company. The incumbent will report into the Vice President of Commercial Strategy and Operations and will serve as a key member of the systemic leadership team to drive insights and market knowledge that will be the foundation for commercialization of Empaveli across indications.

Requirements

Master’s degree required (business, biology, or medicine-related degree preferred).
15+ years of progressive experience in a market insights, analytics, or business intelligence role in the biopharma industry (client-side experience preferred).
Demonstrated success in managing a team of insights and analytics professionals and external vendors.
Ability to identify the right approach to any business question and translate analyses into actionable insights.
Strong attention to detail and commitment to the accuracy and quality of data/insights.
Excellent problem-solving, project management, communication, and leadership management skills.
Work effectively with various functional partners to build consensus.
Ability to influence without authority.
Proven ability to engage with business unit and executive leadership.

Nice To Haves

Advanced Degree (MBA, PhD, PharmD) preferred.
Hematology / Nephrology experience
Rare disease launch experience

Responsibilities

Lead insights, analytics, and field operations for the Rare Portfolio supporting commercialization of Empaveli in Hematology and Nephrology (market research, secondary analytics, competitive intelligence, data operations, sales operations).
Design the insights and analytics plans to best meet the needs of the Rare Portfolio – lead budget planning, identification of data and insights sources, and resourcing.
Act as a thought leader, providing strategic consulting and market perspective to key business stakeholders on strategies, opportunities, and risks.
Lead launch performance reviews internally and be the insights/analytics representative on cross-functional leadership forums.
Manage monthly and quarterly business reviews with U.S. and executive leadership.
Track brand performance and support execution cross-functionally across sales, marketing, patient services, medical, market access.
Lead annual Brand Planning Situation Analysis – compile the most recent and more relevant market and performance insights to lay the groundwork for annual brand planning.
Partner with forecasting to ensure demand estimates, timelines, risks and opportunities and accurately identified and aligned with market insights and performance.
Manage commercial data in collaboration with business partners ensuring accuracy and speed in tracking and reporting performance.
Build KPIs and dashboards to monitor performance, trends, and cross-functional execution.
Manage commercial field operations for Empaveli including territory alignments, targeting, design and implementation of incentive compensation plans, account profiling, and CRM build.
Manage insights projects – market research, secondary data analytics, commercial assessments, competitive intelligence – and ensure input into brand strategies, field execution, and forecasting.
Partner with patient services, trade-distribution and marketing to evaluate the distribution model, patient services program, and the go-to-market field model for the brand.
Lead pipeline commercial assessments for Systemic franchise and create business cases for new opportunities for current brands or new assets.
Collaborate closely with portfolio strategy, NPP, and BD.